Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001193125-26-151312
Filing Date
2026-04-10
Accepted
2026-04-10 16:18:38
Documents
1
Period of Report
2026-03-18

Document Format Files

Seq Description Document Type Size
1 3/A ownership.html 3/A  
1 3/A ownership.xml 3/A 3178
  Complete submission text file 0001193125-26-151312.txt   4710
Mailing Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850
Business Address SUITE 400, 2440 RESEARCH BLVD ROCKVILLE MD 20850 (301) 670 2800
NovaBridge Biosciences (Issuer) CIK: 0001778016 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NOVABRIDGE BIOSCIENCES 2440 RESEARCH BOULEVARD, SUITE 400 ROCKVILLE MD 20850
Business Address
Xu Cong Claire (Reporting) CIK: 0002114309 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-39173 | Film No.: 26855118